TD Cowen lowered its price target for AnaptysBio, and Scotiabank downgraded the stock to hold.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen lowered its price target for AnaptysBio, and Scotiabank downgraded the stock to hold.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Scotiabank
Canadian bank based in Toronto
Related events
- TD Cowen lowered its price target on Paychex, while S&P Global Market Intelligence reported a stock decline.
- TD Cowen lowered its price target for Navan, Inc. stock on September 10, 2026.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- Scotiabank adjusted its target price for Oracle stock, while TD Cowen reiterated a buy rating and Cantor Fitzgerald reaffirmed its overweight rating.
- TD Cowen downgraded Capri's rating and lowered its price target.